• 대한의생명과학회지
• /
• 제17권2호
• /
• pp.113-122
• /
• 2011

Several studies have reported a relation between serum levels of uric acid and a wide variety of cardiovascular conditions. But, the relationship between serum levels of uric acid and coronary artery disease (CAD) is still controversial. The present study was retrospectively designed to investigate whether CAD can be stratified by the level of uric acid and there are the relationships between preoperative levels of uric acid and perioperative biochemical markers in fifty-adult patients that underwent coronary artery bypass grafting surgery (CABG) and twenty-normal subjects. They were divided into the control, the unstable angina (UA-group) and the myocardial infarction group (MI-group). In preoperative levels of uric acid, the MI-group was higher than control and the UA-group. The MI-group had significantly higher correlations than the UA-group between preoperative levels of uric acid and left ventricular ejection fraction, cardiac markers (creatine kinase, lactate dehydrogenase and brain natriuretic peptide), renal markers (blood urea nitrogen and creatinine) or total leukocyte levels. At postoperative periods, the MI-group had higher relationships of uric acid with aspartate aminotransferase, blood urea nitrogen or creatinine levels. Although there was not statistically significant, the UA-group tended to have higher correlation coefficients than the MI-group between preoperative levels of uric acid and intensive care unit-stay (ICU), or postoperative mechanical ventilation time. These results reflect that increased levels of serum uric acid may be a tool for the diagnosis of coronary heart disease and may be considered as a good predictor in assessing the cardiac and renal functions in patients with myocardial infarction or unstable angina at the preoperative period. However, further studies should be performed in a large patient population.

• Journal of Chest Surgery
• /
• 제30권6호
• /
• pp.613-616
• /
• 1997

저자들은 말기 확장성 심부전을 앓아온 58세의 여자환자에게 좌심실 내경을 줄여주는 좌심실개조수술을 시행하여 좌심실기능의 향상을 보았기에 증례보고를 하고자 한다. 본 환자는 1996년 9월에 심부전으로 인한 호흡곤란(NYHA 기능 4도)과 사지부종을 주소로 입원하였다. 입원시 심초음파검사상 좌심실 구축률 15%, 좌 심실 말기이완기 내경이 80mm, 승모판 폐쇄부전 4도, 삼첨판 폐쇄부전 2도였고 심박출량이 1.5L/min였고 심 박출계수는 1.0 L/min/m2 있단 이 환자에게 전방유두근과 후방유두근 사이의 좌심실 측벽을 절제하고 승모 판과 삼첨판 성형술을 실시하는 좌심실개조수술을 시행하였다. 술후 심초음파검사와 혈역학적 평가결과, 좌 심실 구축력 35%, 좌심실 말기이완기내경 50m였고, 승모판 기능 및 삼첨판 기능은 완벽하였다. 심박출량은 2.3L/ms 였고 심박출계수는 2.3umi m2였고 환자의 mID기능은 1도였다.

• Advances in biomechanics and applications
• /
• 제1권1호
• /
• pp.41-55
• /
• 2014

Acellular intra-myocardial biomaterial injections have been shown to be therapeutically beneficial in inhibiting ventricular remodelling of myocardial infarction (MI). Based on a biventricular canine cardiac geometry, various finite element models were developed that comprised an ischemic (II) or scarred infarct (SDI) in left ventricular (LV) antero-apical region, without and with intra-myocardial biomaterial injectate in layered (L) and bulk (B) distribution. Changes in myocardial properties and LV geometry were implemented corresponding to infarct stage (tissue softening vs. stiffening, infarct thinning, and cavity dilation) and injectate (infarct thickening). The layered and bulk injectate increased ejection fraction of the infarcted LV by 77% (II+L) and 25% (II+B) at the ischemic stage and by 61% (SDI+L) and 63% (SDI+B) at the remodelling stage. The injectates decreased the mean end-systolic myofibre stress in the infarct by 99% (II+L), 97% (II+B), 70% (SDI+L) and 36% (SDI+B). The bulk injectate was slightly more effective in improving LV function at the remodelling stage whereas the layered injectate was superior in functional improvement at ischemic stage and in reduction of wall stress at ischemic and remodelling stage. These findings may stimulate and guide further research towards tailoring acellular biomaterial injectate therapies for MI.

• 대한종양외과학회지
• /
• 제14권2호
• /
• pp.102-107
• /
• 2018

Purpose: Cardiotoxicity is a serious late complication of breast cancer treatment. Individual treatment risk of specific drugs has been investigated. However, studies on the evaluation of the composite risk of chemotherapeutic agents are limited. Methods: We retrospectively analyzed the medical records of breast cancer patients who received adjuvant treatment and had available serial echocardiography results. Patients were assigned to subgroups based on chemotherapy containing anthracyclines (A), anthracyclines and taxanes (A+T), and radiotherapy (RT). The development of cardiac disease and serial ejection fraction (EF) were reviewed. EF decline up to 10% from baseline was considered grade 1 cardiotoxicity and EF decline >20% or absolute value <50% was considered grade 2 cardiotoxicity. The most recent medical records and echocardiography results over 1 year of chemotherapy completion were also reviewed. Late cardiotoxicity was defined as a lack of recovery of EF decline or aggravated EF decline from baseline. Results: In total, 123 patients were evaluated. A small reduction in EF was observed after chemotherapy in both chemotherapy groups. There were no significant differences between groups A and A+T in EF decline following chemotherapy. We could not find any differences in composite risk between the chemotherapy groups and the RT group during follow-up. Late cardiotoxicity was seen in 15.45% of patients. During follow-up, three patients were diagnosed with dilated cardiomyopathy. Conclusion: There was no significant composite risk elevation following adjuvant treatment of breast cancer. However, late cardiotoxicity was considerable and further research in this direction is necessary.

• Journal of Medicine and Life Science
• /
• 제19권2호
• /
• pp.46-56
• /
• 2022

The incidence of fever complicating percutaneous coronary intervention (PCI) is rare. However, little is known regarding the cause of fever after PCI. Therefore, this study aimed to determine the clinical characteristics of patients with acute myocardial infarction (AMI), with or without fever, after PCI. We enrolled a total of 926 AMI patients who underwent PCI. Body temperature (BT) was measured every 4 hours or 8 hours for 5 days after PCI. Patients were divided into two groups according to BT as follows: BT<37.7℃ (no-fever group) and BT ≥37.7℃ (fever group). The 2 years clinical outcomes were compared subsequently. Fever after PCI was associated with higher incidence of major adverse cardiac events (MACE) (hazard ratio [HR], 1.56; 95% confidence interval [CI], 1.07-2.28; P=0.021), all-cause death (HR, 2.32; 95% CI, 1.18-4.45; P=0.014), cardiac death (CD) (HR, 2.57; 95% CI, 1.02-6.76; P=0.049), and any revascularization (HR, 1.69; 95% CI, 1.02-2.81; P=0.044) than without fever. In women, prior chronic kidney disease, lower left ventricular (LV) ejection fraction, higher LV wall motion score index, white blood cell count, peak creatine kinase-myocardial band level, and longer PCI duration were associated with fever after PCI. Procedures such as an intra-aortic balloon pump, extracorporeal membrane oxygenation, continuous renal replacement therapy, central and arterial line insertion, and cardiopulmonary resuscitation were related to fever after PCI. Fever after PCI in patients with AMI was associated with a higher incidence of MACE, all-cause death, CD, and any revascularization at the 2 years mark than in those without fever.

• Journal of Cardiovascular Imaging
• /
• 제30권4호
• /
• pp.263-275
• /
• 2022

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a complication beyond the first-year post-heart transplantation (HTx). We aimed to test the utility of cardiac magnetic resonance (CMR) to detect functional/structural changes in HTx recipients with CAV. METHODS: Seventy-seven prospectively recruited HTx recipients beyond the first-year post-HTx and 18 healthy controls underwent CMR, including cine imaging of ventricular function and T1- and T2-mapping to assess myocardial tissue changes. Data analysis included quantification of global cardiac function and regional T2, T1 and extracellular volume based on the 16-segment model. International Society for Heart and Lung Transplantation criteria was used to adjudicate CAV grade (0-3) based on coronary angiography. RESULTS: The majority of HTx recipients (73%) presented with CAV (1: n = 42, 2/3: n = 14, 0: n = 21). Global and segmental T2 (49.5 ± 3.4 ms vs 50.6 ± 3.4 ms, p < 0.001;16/16 segments) were significantly elevated in CAV-0 compared to controls. When comparing CAV-2/3 to CAV-1, global and segmental T2 were significantly increased (53.6 ± 3.2 ms vs. 50.6 ± 2.9 ms, p < 0.001; 16/16 segments) and left ventricular ejection fraction was significantly decreased (54 ± 9% vs. 59 ± 9%, p < 0.05). No global, structural, or functional differences were seen between CAV-0 and CAV-1. CONCLUSIONS: Transplanted hearts display functional and structural alteration compared to native hearts, even in those without evidence of macrovasculopathy (CAV-0). In addition, CMR tissue parameters were sensitive to changes in CAV-1 vs. 2/3 (mild vs. moderate/severe). Further studies are warranted to evaluate the diagnostic value of CMR for the detection and classification of CAV.

• Clinical and Experimental Pediatrics
• /
• 제49권11호
• /
• pp.1202-1210
• /
• 2006

목 적 : Tei 지수는 전반적인 심기능을 양적으로 쉽게 측정할 수 있는 장점이 있으나 심박동수, 전부하, 후부하에 영향을 받을 수 있으며 같은 심장 cycle에서 측정하기 어려운 단점이 제시되고 있다. 이에 반해 modified Tei 지수는 TDI을 이용하여 같은 cycle 내에서 측정 가능하기 때문에 기존의 Tei 지수의 단점을 보완할 수 있는 새로운 방법으로 제시되고 있다. 방 법 : 가와사키병의 급성기 환아 48명을 두 군(modified Tei 지수가 0.37 미만인 24명을 1군, modified Tei 지수가 0.37 이상인 24명을 2군), 그리고 열이 없는 정상 소아 30명을 대조군인 3군으로 나누어 연구를 시행하였다. 혈액 검사, TDI, 고식적인 심초음파를 시행하였다. 수축기 심근 속도, 초기 이완기(E') 심근 속도, 그리고 후기 이완기(A') 심근 속도와 조직 이동을 심저, 심중간부, 심첨에서 측정하였다. Ejection fraction(EF), Tei 지수, modified Tei 지수를 계산하였다. 결 과 : 백혈구수와 CRP는 2군에서 대조군에 비해 유의하게 높았다. 좌심실 기저부 수축기 심근 조직 이동, 초기 이완기 및 후기 이완기 심근 조직 이동이 2군에서 대조군에 비해 유의하게 감소하였다. Modified Tei 지수와 심실 기저부의 수축기 심근조직 이동(r=0.331), 초기 이완기(E') 심근 조직 이동(r=0.296), 그리고 후기 이완기(A') 심근 조직 이동(r=0.266)이 음의 상관관계를 보였다. Modified Tei 지수가 증가할수록 ESR(r=0.561)과 CRP(r=0.427)가 유의하게 증가하는 양의 상관관계가 보였다. EF과 Tei 지수는 정상이었다. 결 론 : 가와사키병에서 TDI를 이용한 modified Tei 지수는 EF이나 Tei 지수로 구별되지 않았던 심기능 이상을 발견하는데 매우 도움이 되는 유용한 지표로 생각된다.

• 대한핵의학회지
• /
• 제28권1호
• /
• pp.52-61
• /
• 1994

Background : The demand for refinement in noninvasive and quantitative assessment of left ventricular (LV) function is increasing. Purpose : To assess normal values of left ventricular functional parameters during both systole and diastole by scintigraphic method using computerized triple-head gamma camera and to evaluate correlations between these parameters. Methods : ECG gated blood pool scan with $^{99m}Tc$-Human serum albumin was performed in 94 normal Korean subjects. Ejection fraction (EF), systolic parameters [peak emptying rate (PER), average emptying rate (AER), time to peak emptying rate (TPER)], and diastolic parameters [peak filling rate (PFR), average filling rate (AFR), time to peak filling rate (TPFR)] were obtained by analysis of LV time-activity curve, the correlation of these parameters to the age and sex, and the correlation between these parameters were evaluated. Results : 1) Mean value of ejection fraction in study subjects was $59.6{\pm}5.25%$ and showed no significant correlation to age (r=-0.08) and sex but showed most pronounced correlation to PFR (r=0.46, p<0.001), PER (r=0.41, p<0.001), AFR (r=0.34, p<0.001) and AER (r=0.28, p<0.01). 2) Mean values of systolic parameters were as follows: $PER=3.22{\pm}0.50$ end-diastolic volume/sec, $AER=2.22{\pm}0.45$ end-diastolic volume/sec, $TPER=103.5{\pm}29.30$ msec. They showed no significant correlation to age and sex. 3) Mean values of diastolic parameters were as follows: $PFR=2.71{\pm}0.51$ end-diastolic volume/sec, $AFR=1.83{\pm}0.44$ end-diastolic volume/sec, $TPFR=132.1{\pm}33.45$ msec. They showed strong correlation to age (r=0.70, -0.64, 0.37, p<0.001). Conclusions : Left ventricular functional parameters in normal Korean subjects were obtained reliably by computerized scintigraphic method and may be applied to the evaluation of cardiac function in diseased patients.

• Journal of Chest Surgery
• /
• 제23권6호
• /
• pp.1180-1190
• /
• 1990

96 patients underwent cardiac valve replacement for valvular heart diseases consecutively between February 1986 to February 1990 in the Department of Thoracic and Cardiovascular Surgery of Yeungnam University Hospital. The follow up period was between 6 months and 4.5 years postoperatively[mean 23.4$\pm$13.1 months]. 75 cases got mitral valve replacement, 6 cases, aortic valve replacement, 15 cases, double valve replacement. 30[31.2%] patients were male and 66[68.8%] were female and the age ranged from 14 to 66 years old. Early hospital death within 30 days postoperation were 5 patients[5.2%], consisting of by low cardiac output in 2, infective endocarditis in 1, multiple organ failure with sepsis in 1 patient. There was no late postoperative death. Most common early postoperative complication was wound disruption [8.7%] and then low cardiac output, pneumothorax, pleural effusion in order. Most common late postoperative complications were minor bleeding episodes[8.7%] related to anticoagulant therapy which were consisted of frequent epistaxis in 3, gum bleeding in 2, hemorrhagic gastritis in 1, hypermenorrhea in 1, hematoma in right arm in 1 patient. Valve-related complications included valve thrombosis [1.6%/ patient-year], valve failure due to pannus formation[1.1% /patient-year], prosthetic valve endocarditis[1, 1%o/patient-year] and minor anticoagulant hemorrhage[4.4% /patient-year]. 5 cases of reoperations were performed in 4 patients due to valve failure and all of them were in the mitral positions[2.7% /patient-year]. Cardiothoracic ratios in the chest X-ray decreased at the 6th month and 1st year postoperation in all patients. But in New York Heart Association[NYHA] functional class IV, no change in cardiothoracic ratio was found between 6 months and 1 year postoperation. In the echocardiogram, the size of the cardiac chambers decreased, but ejection fraction increased postoperatively in each functional class. In the electrocardiogram, decreases were found in the incidence of atrial fibrillation, left atrial enlargement, left ventricular hypertrophy with right bundle branch block increasing postoperatively in each functional class. The actuarial survival rate was 98.4% for all patients, 98.7% for mitral valve replacement, 83.8% for aortic valve replacement, and 80% for double valve replacement at the end of a 4.5 year follow up period. Meanwhile the actuarial freedom rate was 91.5% for prosthetic valve endocarditis, 91.6% for thromboembolism, 89.0% for prosthetic valve failure and 83.7% for minor anticoagulant hemorrhage. Preoperative NYHA class III and IV were 75% of all patients, but 95% of all patients were up graded to NYHA class I and II postoperatively.

• 생명과학회지
• /
• 제20권10호
• /
• pp.1458-1467
• /
• 2010

이 연구는 관상동맥질환 수술기주위의 결과예측에 있어 수술 전 백혈구 및 D-dimer 수치가 유용한 인자가 될 수 있는지를 규명하기 위해 회고적으로 실시하였다. 수술 전 백혈구 수는 수술 전 및 후의 심장표지자인 troponin-I, creatine kinase-MB, C-반응단백 각각의 농도와 정의 상관성이 있었다. 수술 전 D-dimer 농도 역시 수술기주위의 심장표지자들과 정의 상관관계를 보였다. 수술 전 백혈구 수는 간표지자인 aspartate aminotransferase 및 alanine aminotransferase의 수술 전후 농도와 정의 상관관계를 보였는데 비해, 수술 전 D-dimer 농도는 수술 전후 빌리루빈 농도, 수술 전 글루코스 농도, 수술 후 크레아티닌 농도와 각각 정 또는 역의 상관관계가 있었다. 수술 전 백혈구 및 D-dimer 수치 둘 다 수술 전 고밀도콜레스테롤 농도 및 좌심실구출계수와 각각 역의 상관관계가 있었다. 수술전 백혈구 수는 수술시간 및 수술 후 기계보조 호흡시간과 각 정의 상관관계를 보였고, 수술 전 D-dimer 농도는 수술 후 기계보조 호흡시간, 중환자실 치료기간, 재원기간과 각 정의 상관관계가 있었다. 이 회고적 조사의 결과는 수술 전 백혈구 및 D-dimer 수치가 관상동맥수술 환자들의 수술기주위 결과예측에 있어 임상적으로 유용한 인자들이 될 수 있음을 시사하고 있다.